Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, Kazuo Morita, Tomoyo Shimamoto, Toshifumi Hibi
Intest Res. 2021;19(3):301-312.   Published online 2020 Aug 20     DOI: https://doi.org/10.5217/ir.2020.00013
Citations to this article as recorded by Crossref logo
A Contemporary Review of Behcet’s Syndrome
Jingjing Chen, Xu Yao
Clinical Reviews in Allergy & Immunology.2021; 61(3): 363.     CrossRef
Behçet syndrome
Yusuf Yazici, Gulen Hatemi, Bahram Bodaghi, Jae Hee Cheon, Noburu Suzuki, Nicola Ambrose, Hasan Yazici
Nature Reviews Disease Primers.2021;[Epub]     CrossRef
C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet’s disease
Eun Ae Kang, Jung Won Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Min Soo Cho, Jae Hee Cheon
BMC Gastroenterology.2021;[Epub]     CrossRef